Primary myelofibrosis and its paraneoplastic stromal effects

During its most recent meeting (November 2006), the International Working Group for Myelofibrosis Research and Treatment (IWG-MRT) recommended the use of the name primary myelofibrosis (PMF) for the clinicopathologic entity otherwise known as chronic idiopathic myelofibrosis, agnogenic myeloid